COMBINATION COMPRISING A CDK INHIBITOR AND CISPLATIN

摘要

A first aspect of the invention relates to a combination comprising a CDK inhibitor and cisplatin. A second aspect of the invention relates to a pharmaceutical product comprising a CDK inhibitor and cisplatin as a combined preparation for simultaneous, sequential or separate use in therapy. A third aspect of the invention relates to a method of treating a proliferative disorder, said method comprising simultaneously, sequentially or separately administering a CDK inhibitor and cisplatin to a subject.